Punam Malik

Mechanisms Underlying Increased Risk of Hematological Malignancy in Sickle Cell Disease.

National Cancer Institute · R21

Contact PI · $412.7K · Cincinnati Childrens Hosp Med Ctr

Regulation of Hematopoietic Stem Cell Self-Renewal by GTPase Activating Protein Signaling

National Institute of Diabetes and Digestive and Kidney Diseases · R01

PI · $1.7M · Cincinnati Childrens Hosp Med Ctr

Cincinnati Center of Excellence in Hemoglobinopathies Research

National Heart, Lung, and Blood Institute · U01

Contact PI · $8.9M · Cincinnati Childrens Hosp Med Ctr

PlGF-HIF1a-miRNA Axis in Sickle Pulmonary Hypertension

National Heart, Lung, and Blood Institute · R01

PI · $3.1M · University of Southern California

Losartan to Reverse Sickle Nephropathy

Principal investigator · Completed · Phase 2

Children's Hospital Medical Center, Cincinnati

Trial of Zileuton CR in Children and Adults With Sickle Cell Disease

Principal investigator · Completed · Phase 1

Children's Hospital Medical Center, Cincinnati

Screening Patients With Sickle Cell Disease for Kidney Damage

Principal investigator · Completed

Children's Hospital Medical Center, Cincinnati

Role of Placenta Growth Factor in Sickle Acute Chest Syndrome

Study chair · Completed

Children's Hospital Medical Center, Cincinnati